Israeli investors cap Quantum X (QXL) stake just under 10% with warrants

Rhea-AI Filing Summary

Quantum X Labs Inc. (QXL) received an updated ownership report from Israeli investors L.I.A. Pure Capital Ltd. and Xylo Technologies Ltd. The Reporting Persons together beneficially own 2,179,600 shares of common stock, representing 9.99% of the outstanding 21,817,826 shares, based on information provided by the company. This position includes 1,727,817 shares held by L.I.A. Pure Capital, 315,066 shares held by Xylo, and 136,717 shares that L.I.A. Pure Capital may acquire within 60 days through warrant exercise, all subject to blocker provisions. Additional pre-funded and regular warrants held by L.I.A. Pure Capital, totaling potential acquisition of 1,742,998 shares, are excluded from the reported beneficial ownership because 4.99% ownership caps limit when they can be exercised.

Key Figures

Total shares outstanding: 21,817,826 shares Total shares beneficially owned (Reporting Persons): 2,179,600 shares Combined ownership percentage: 9.99% +5 more

8 metrics

Total shares outstanding 21,817,826 shares Common stock of Quantum X Labs Inc. outstanding as of the reporting date

Total shares beneficially owned (Reporting Persons) 2,179,600 shares Combined beneficial ownership of L.I.A. Pure Capital Ltd. and Xylo Technologies Ltd.

Combined ownership percentage 9.99% Portion of Quantum X Labs’ outstanding common stock beneficially owned by the Reporting Persons

Xylo Technologies share holdings 315,066 shares Common shares of Quantum X Labs held by Xylo Technologies Ltd.

Xylo ownership percentage 1.44% Portion of Quantum X Labs’ outstanding common stock held by Xylo Technologies Ltd.

Warrants included in beneficial ownership 136,717 shares Shares acquirable by L.I.A. Pure Capital within 60 days via warrants, counted in beneficial ownership

Pre-funded warrant shares excluded 1,292,998 shares Additional shares acquirable by L.I.A. Pure Capital via pre-funded warrant, excluded due to blocker

Additional warrant shares excluded 450,000 shares Shares acquirable via another warrant held by L.I.A. Pure Capital, excluded due to blocker

Key Terms

beneficial ownership, pre-funded warrant, blocker provision, Joint Filing Agreement, +1 more

5 terms

beneficial ownership financial

"Amount beneficially owned by the Reporting Persons consists of (i) 1,727,817 Shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pre-funded warrant financial

"1,292,998 Shares which may be acquired by Pure Capital within 60 days"

A pre-funded warrant is a financial instrument that gives the holder the right to buy shares of a company's stock at a set price, with most of the purchase cost already paid upfront. It functions like a nearly fully paid option, allowing investors to secure shares quickly while minimizing the amount of additional money they need to invest later. This helps investors gain ownership rights efficiently, often used to avoid certain regulatory restrictions or to prepare for future stock purchases.

blocker provision financial

"which includes a blocker provision under which Pure Capital does not have the right"

Joint Filing Agreement regulatory

"The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed"

percentage of class financial

"See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class"

FAQ

How many Quantum X Labs Inc. (QXL) shares do L.I.A. Pure Capital and Xylo Technologies beneficially own?

L.I.A. Pure Capital and Xylo Technologies together beneficially own 2,179,600 Quantum X Labs common shares, equal to 9.99% of the company’s 21,817,826 shares outstanding. This total includes currently held shares plus certain warrants exercisable within 60 days, subject to ownership limits.

What is L.I.A. Pure Capital Ltd.’s individual ownership stake in Quantum X Labs (QXL)?

L.I.A. Pure Capital’s position totals 2,179,600 shares for reporting purposes, equal to 9.99% of Quantum X Labs’ outstanding shares. This consists of 1,727,817 shares held directly, plus 136,717 shares acquirable via warrants within 60 days, and indirect ownership of Xylo’s shares.

How many Quantum X Labs (QXL) shares does Xylo Technologies Ltd. hold?

Xylo Technologies Ltd. holds 315,066 Quantum X Labs common shares, representing 1.44% of the 21,817,826 shares outstanding. L.I.A. Pure Capital, as Xylo’s parent, may be deemed to beneficially own these shares, while expressly disclaiming beneficial ownership beyond its pecuniary interest.

What warrant rights related to Quantum X Labs (QXL) does L.I.A. Pure Capital hold?

L.I.A. Pure Capital may acquire 136,717 shares within 60 days via warrants included in the 9.99% stake, and holds additional warrants for 1,292,998 pre-funded shares and 450,000 warrant shares. These extra warrants are excluded from beneficial ownership due to blocker provisions.

What are the ownership blocker provisions affecting Quantum X Labs (QXL) warrants?

The warrants held by L.I.A. Pure Capital include a 4.99% ownership blocker. They cannot be exercised if doing so would cause L.I.A. Pure Capital, its affiliates, and any group members to beneficially own more than 4.99% of Quantum X Labs’ outstanding common shares through those instruments.

Where are Quantum X Labs Inc. (QXL) and the reporting investors based?

Quantum X Labs’ principal executive offices are in Ramat Gan, Israel. L.I.A. Pure Capital Ltd. and Xylo Technologies Ltd. are both companies incorporated under the laws of the State of Israel, with principal offices in Tel Aviv, Israel.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:16 PM Accepted by SEC EDGAR 08/19/2026 - 04:15 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Quantum X Labs Inc. (formerly known as Viewbix Inc.)

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

926711300

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 926711300

1

Names of Reporting Persons

L.I.A. Pure Capital Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ISRAEL

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,179,600.00
6	Shared Voting Power 2,179,600.00
7	Sole Dispositive Power 2,179,600.00
8	Shared Dispositive Power 2,179,600.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,179,600.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: *Percentage calculated based on 21,817,826 shares of common stock, $0.0001 par value per share (the "Shares"), of Quantum X Labs Inc. (the "Issuer") issued and outstanding as of the date hereof, which amount was provided to the Reporting Person by the Issuer.

SCHEDULE 13G

CUSIP Number(s): 926711300

1

Names of Reporting Persons

Xylo Technologies Ltd.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

ISRAEL

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 315,066.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 315,066.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

315,066.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

1.44 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: *Percentage calculated based on 21,817,826 shares of common stock, $0.0001 par value per share (the "Shares"), of Quantum X Labs Inc. (the "Issuer") issued and outstanding as of the date hereof, which amount was provided to the Reporting Person by the Issuer.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Quantum X Labs Inc. (formerly known as Viewbix Inc.)
(b)	Address of issuer's principal executive offices: Atrium Tower, 2 Jabotinsky Street, Ramat Gan, Israel 5252903
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed by each of L.I.A. Pure Capital Ltd., a company incorporated under the laws of the State of Israel, and Xylo Technologies Ltd., a company incorporated under the laws of the State of Israel (each, a "Reporting Person" and together, the "Reporting Persons"). The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit A, pursuant to which the Reporting Persons have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k)(1) of the Securities Exchange Act of 1934, as amended.
(b)	Address or principal business office or, if none, residence: The address of the principal business office of each Reporting Person is 20 Raoul Wallenberg Street, Tel Aviv, Israel 6971916.
(c)	Citizenship: Each of the Reporting Persons is a company incorporated under the laws of the State of Israel.
(d)	Title of class of securities: Common Stock, $0.0001 par value per share
(e)	CUSIP No.: 926711300
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which is incorporated herein. Amount beneficially owned by the Reporting Persons consists of (i) 1,727,817 Shares held by L.I.A. Pure Capital Ltd. ("Pure Capital"), (ii) 315,066 Shares held by Xylo Technologies Ltd. and (iii) 136,717 Shares which may be acquired by Pure Capital within 60 days of the date hereof through the exercise of warrants, which includes a blocker provision under which Pure Capital does not have the right to exercise the warrant to the extent (but only to the extent) that such exercise would result in beneficial ownership by Pure Capital, together with Pure Capital's affiliates, and any other persons acting as a group together with Pure Capital or any of Pure Capital's affiliates, of more than 4.99% of the Shares. Such amount does not include (i) 1,292,998 Shares which may be acquired by Pure Capital within 60 days of the date hereof through the exercise of a pre-funded warrant, which includes a blocker provision under which Pure Capital does not have the right to exercise the warrant to the extent (but only to the extent) that such exercise would result in beneficial ownership by Pure Capital, together with Pure Capital's affiliates, and any other persons acting as a group together with Pure Capital or any of Pure Capital's affiliates, of more than 4.99% of the Shares and (ii) 450,000 Shares which may be acquired by Pure Capital within 60 days of the date hereof through the exercise of a warrant, which includes a blocker provision under which Pure Capital does not have the right to exercise the warrant to the extent (but only to the extent) that such exercise would result in beneficial ownership by Pure Capital, together with Pure Capital's affiliates, and any other persons acting as a group together with Pure Capital or any of Pure Capital's affiliates, of more than 4.99% of the Shares. L.I.A. Pure Capital Ltd. does not directly own any shares of the Issuer's common stock held by Xylo Technologies Ltd. L.I.A. Pure Capital Ltd., as parent of Xylo Technologies Ltd. may be deemed a beneficial owner of any shares of the Issuer's common stock beneficially owned by Xylo Technologies Ltd. Each of the Reporting Persons specifically disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
(b)	Percent of class: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Persons, which is incorporated herein.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Persons, which is incorporated herein.
	(ii) Shared power to vote or to direct the vote: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Persons, which is incorporated herein.
	(iii) Sole power to dispose or to direct the disposition of: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Persons, which is incorporated herein.
	(iv) Shared power to dispose or to direct the disposition of: See items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Persons, which is incorporated herein.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

L.I.A. Pure Capital Ltd.

Signature:	/s/ Kfir Silberman
Name/Title:	Kfir Silberman / Chief Executive Officer
Date:	08/19/2026

Xylo Technologies Ltd.

Signature:	/s/ Kfir Silberman
Name/Title:	Kfir Silberman / Chief Executive Officer
Date:	08/19/2026

Exhibit Information

Exhibit 99.1 - Joint Filing Agreement